Alnylam Pharmaceuticals, Inc. (LON:0HD2)
London
· Delayed Price · Currency is GBP · Price in USD 291.48
+6.75 (2.37%)
At close: May 27, 2025
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of 29.54 billion as of June 6, 2025. Its market cap has increased by 98.49% in one year.
Market Cap
29.54B
Enterprise Value
29.61B
Revenue
1.82B
Ranking
n/a
PE Ratio
n/a
Stock Price
291.48
Market Cap Chart
Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 63.23M to 29.54B, an increase of 46,624.98%. That is a compound annual growth rate of 33.93%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 164.96B |
| GSK plc | 60.20B |
| Haleon | 36.46B |
| Smith & Nephew | 9.47B |
| ConvaTec Group | 5.94B |
| Hikma Pharmaceuticals | 4.70B |
| HUTCHMED (China) | 1.86B |
| Genus | 1.29B |